Showing results 22 to 32 of 32
< previous
Title | Author(s) | Issue Date | |
---|---|---|---|
Safety and antiviral activity of VIR-2218, an X-targeting RNAi therapeutic, in participants with chronic hepatitis B infection: week 48 follow-up results Proceeding/Conference:Journal of Hepatology | 2021 | ||
Safety and pharmacodynamics of the GALNAC-siRNA AB-729 in subjects with chronic hepatitis B infection Proceeding/Conference:Hepatology | 2020 | ||
12-Jan-2023 | |||
4-Oct-2022 | |||
Safety, pharmacokinetics, and antiviral effects of ABI-H0731, a hepatitis B virus core inhibitor: a randomised, placebo-controlled phase 1 trial Journal:The Lancet Gastroenterology & Hepatology | 2020 | ||
2018 | |||
2018 | |||
Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of HBeAg-positive chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial Journal:The Lancet Gastroenterology & Hepatology | 2016 | ||
2016 | |||
2018 | |||
2018 |